نتایج جستجو برای: ifn therapy
تعداد نتایج: 685719 فیلتر نتایج به سال:
conclusions our findings indicate that heterogeneity at +2109 locus of ifn-γ gene but not at +874 locus could interfere with successful therapy in patients infected with hcv genotype 1. results of 158 patients, 110 (69.5%) subjects achieved svr and 48 (30.5%) subjects did not respond to therapy. the frequency of aa genotype (p = 0.001; or: 11.2; ci: 2.26-63.21) and a allele (p = 0.01; or: 3.23;...
hepatitis c virus (hcv) envelope glycoprotein-2 (e2) inhibits the interferon (ifn)–induced, double –stranded rna activated protein kinase (pkr) via pkr eukaryotic initiation factor-2α phosphorylation homology domain (pephd). present study examined the genetic variability of the pephd in patients receiving interferon therapy. the pephd region from hcv genotype 1a/1b infected patients receiving i...
Davoudi-Monfared et al. (1) report in this journal the results from a clinical trial on coronavirus disease 2019 (COVID-19) patients showing that subcutaneous administration of interferon beta (IFN-β) was associated with more rapid recovery severe acute respiratory syndrome 2 (SARS-CoV-2) infection and decreased mortality. These findings have been corroborated by two recent phase trials during ...
conclusions this study supports the idea that the ifnl3 gene is an important predictor of the response of chb patients to ifn therapy. results nine studies of 1602 chb patients receiving ifn treatment were included. under the random-effects model, patients expressing the variant rs12980275 showed a significantly increased response to ifn therapy (or = 2.85; 95% ci = 1.14 - 4.60). in the subgrou...
Hepatitis C virus (HCV) envelope glycoprotein-2 (E2) inhibits the interferon (IFN)–induced, double –stranded RNA activated protein kinase (PKR) via PKR eukaryotic initiation factor-2α phosphorylation homology domain (PePHD). Present study examined the genetic variability of the PePHD in patients receiving interferon therapy. The PePHD region from HCV genotype 1a/1b infected patients receiving I...
The cytokine interferon gamma (IFN-γ) and doxorubicin mono-therapy has been approved by the Food Drug Administration (FDA) for treatment of tumors. importance IFN-γ in immune system lies its immunomodulatory effects, antitumor therapy inhibiting RNA DNA synthesis. In this work, role activity combination with was investigated. Meanwhile, used as a vehicle to load over immunotherapy chemotherapy ...
Hepatitis C virus infection is affecting an estimated 200 million people worldwide and 210 thousand in Iran. It is a major cause of morbidity and mortality from liver disease. Interferon-alpha is the choice of treatment but interferone (IFN) with ribavirin is known more effective recently. This study evaluated effect of IFN on Iranian patients and predict response to therapy. This i...
allergic rhinitis (ar) is one of the most common chronic diseases in the developed countries. this study was performed to investigate the effect of cpg-odn in alteration of t-helper (th)1/th2 balance of patients with ar treated with intranasal corticosteroids (incs) and antihistamines. peripheral blood mononuclear cells (pbmcs) of 20 patients with ar were isolated before and after 45 days thera...
Oncolytic virotherapy represents a new approach in the treatment of metastatic melanoma. The efficacy this therapeutic is limited by release type I IFNs tumor microenvironment that can induce an antiviral state cells. Here we investigated ability to impair oncolytic virolysis panel human melanoma cell lines. We found cells with dedifferentiated phenotype showed increased IFN mediated resistance...
conclusions our results indicated a reversible increase in rbv bioavailability after telaprevir exposure, which might be linked to the impairment of the gfr. this also suggests a rbv-telaprevir pharmacological interaction, a possible source of severe anemia observed under triple therapy. these results suggest that rbv pharmacological monitoring may be clinically relevant, especially in the cont...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید